Like its core product Spontan, biotech LTR Pharma (ASX:LTP) is relying on speed as its advantage. The company is set on taking an agile approach, using its intranasal drug delivery technology and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback